Clinical Research Directory

Inclusion Criteria: * Age ≥ 18 years old; * FINDRISC Score ≥12 (moderate, high or very high) and/or prediabetes, defined as either: * HbA1c between 5.7%-6.4% within the last two years; or * Impaired Glucose Tolerance (IGT) based on an Oral Glucose Tolerance Test (OGTT) at the 120-minute mark, with values between 140 and 199 mg/dL in the past three years; * Able to understand, speak and write Portuguese; * Able to provide written informed consent; * Access to a smartphone, tablet or computer with internet connection; * Plan to reside in the recruitment/study area for the next 10 months Exclusion Criteria: * Established Type 1 and 2 Diabetes Mellitus diagnosis; * Pregnancy - Self-reported as currently pregnant, planning to become pregnant, or not practicing contraception, in the following 10 months (if applicable); * Conditions precluding technology use (e.g. cognitive decline, dependent upon a carer for daily activities); * Use of anti-obesity or diabetes medication, such as Metformin, Glucagon-like peptide-1 analogue (GLP-1), or other medications known to significantly impact weight (either gain or loss), currently or within the preceding 3 months; * Following a prescribed medical diet; * Having undergone bariatric surgery within the past 3 years or planning surgery within the next 10 months; * Any mental health condition, including, but not limited to, eating disorders or alcohol/substance abuse, that would impact fully participating on the study; * Participating in a concurrent weight management program and/or relevant interventional research protocol; * Contraindication to physical activity or weight loss; * Existing thyroid disorder; * Active cancer or less than 6 months from treatment; * Unable to provide informed consent or absence of a legal representative that can provided it on behalf of the patient; * Institutionalised adults; * Foreseeable difficulty in attending study visits.